Acorah Software Products - Accounts Production 15.0.600 false true 31 January 2023 1 February 2022 false 1 February 2023 31 January 2024 31 January 2024 10665744 Mr KAUSHIK KANTILAL AMLANI iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10665744 2023-01-31 10665744 2024-01-31 10665744 2023-02-01 2024-01-31 10665744 frs-core:ShareCapital 2024-01-31 10665744 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31 10665744 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 10665744 frs-bus:AbridgedAccounts 2023-02-01 2024-01-31 10665744 frs-bus:SmallEntities 2023-02-01 2024-01-31 10665744 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 10665744 frs-bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 10665744 frs-bus:Director1 2023-02-01 2024-01-31 10665744 frs-countries:EnglandWales 2023-02-01 2024-01-31 10665744 2022-01-31 10665744 2023-01-31 10665744 2022-02-01 2023-01-31 10665744 frs-core:ShareCapital 2023-01-31 10665744 frs-core:RetainedEarningsAccumulatedLosses 2023-01-31
Registered number: 10665744
MEDIC888 PHARMA LTD
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 January 2024
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3
Page 1
Abridged Balance Sheet
Registered number: 10665744
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Cash at bank and in hand 12,439 12,439
12,439 12,439
Creditors: Amounts Falling Due Within One Year (17,317 ) (17,317 )
NET CURRENT ASSETS (LIABILITIES) (4,878 ) (4,878 )
TOTAL ASSETS LESS CURRENT LIABILITIES (4,878 ) (4,878 )
NET LIABILITIES (4,878 ) (4,878 )
CAPITAL AND RESERVES
Called up share capital 4 1 1
Profit and Loss Account (4,879 ) (4,879 )
SHAREHOLDERS' FUNDS (4,878) (4,878)
Page 1
Page 2
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 January 2024 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr KAUSHIK KANTILAL AMLANI
Director
18/10/2024
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
MEDIC888 PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10665744 . The registered office is Bregroup, , Block 15-3,, Room 105d Bucknalls Bricket Wood, , Watford, England, , WD25 9NH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1 1
Page 3